Real-time enrollment status for this pancreatic cancer non-resectable clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 6:40 AM UTC
| NCT Number | NCT06605430 |
| Recruiting Status | Recruiting |
| Condition | Pancreatic Cancer Non-resectable |
| Phase | PHASE2 |
| Target Enrollment | 64 participants |
| Active Locations | 1 sites in the US |
| Sponsor | HealthPartners Institute |
| Last Updated on CT.gov | July 29, 2025 (Jul 29, 2025) |
As of July 19, 2026: Clinical trial NCT06605430 is currently recruiting participants. This phase2 study for pancreatic cancer non-resectable is actively seeking new participants at 1 location across the United States. The study is sponsored by HealthPartners Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06605430 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06605430 was last updated Jul 29, 2025 (July 29, 2025). HelloStudys verifies this status automatically.